Susceptibility Testing of Fungi and Correlation with Clinical Outcome

REFERENCES

• Anaissie EJ, Bodey GP, Rinaldi MG. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989; 8:323-330.
   PubMed Web of Science ®Google Scholar
• Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991; 91 (Suppl 3B):86-89.
   Google Scholar
• Pfaller MA, Wenzel II. The impact of changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11:287-291.
   PubMed Web of Science ®Google Scholar
• Richardson MD. Opportunistic and pathogenic fungi. J Antimicrob Chemotber 1991; 28 (suppl A): 1-11.
   Google Scholar
• Horsburgh CR, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med 1983; 74:23-29.
   PubMedGoogle Scholar
• Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. Clin Microbiol 1984; 20: 1194-1195.
   Google Scholar
• Stiller RL, Bennett JE, Scholer HJ, Wall M, Polak A, Stevens DA. Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States. Antimicrob Agents Chemother 1982; 22: 482-487.
   PubMed Web of Science ®Google Scholar
• Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Sarai R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylacticallv with fluconazole. N Engl J Med 1991; 325: 1274-1277.
   PubMed Web of Science ®Google Scholar
• Ghannoum MA. Future of antimycotic therapy. Dermatology Therapy (in press) 1997.
   Google Scholar
• Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1991; 29: 1089-1094.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Kish CW, Kerkering TM, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992;30:3138-3145.
   PubMed Web of Science ®Google Scholar
• Fromtling RA, Galgiani JN, Pfaller MA et al. Multicenter evaluation of a macrobroth antifungal susceptibility test for veasts. Antimicrob Agents Chemother 1993; 37: 39-45.
   PubMed Web of Science ®Google Scholar
• Guinet R, Nerson D, DeClosets F, et al. Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing. J Clin Microbiol 1988; 26: 2307-2312.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol 1988; 26: 1437-1441.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Rinaldi MG, Galgiani JN et al. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother 1990; 34: 1648-1654.
   PubMed Web of Science ®Google Scholar
• Polak A, Ansorg R, Bartmann K et al. Multizenter-Studie zur Standardisierung der Empfindlichkeitsbestimmung von Pilzen gegen 5-Fluorocytosin und Amphotericin B. Mykosen 1987; 30: 306-314.
   PubMedGoogle Scholar
• Shawar R, Paetznick V, Witte Z, Ensign LG, Anaissie E, LaRocco M. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans. J Clin Microbiol 1992; 30: 1976-1981.
   PubMed Web of Science ®Google Scholar
• Troke PF and the Fluconazole Susceptibility Testing Group. Standardized susceptibility testing of fluconazole: a nine-centre, international collaborative study. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1992: No. 1596.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. M27-P. National Committee for Clinical Laboratory Standards, Villanova, PA, 1992.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard, M27-T. National Committee for Clinical Laboratory Standards, Villanova, PA, 1995.
   Google Scholar
• Ghannoum MA, Ibrahim AS, Fu Y, Shafiq MC, Edwards JE, Criddle RS. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. Clin Microbiol 1992; 30: 2881-2886.
   Google Scholar
• Rex JH, Cooper Jr CR, Merz WG, Galgiani JN, Anaissie EJ. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 1995; 39: 906-909.
   PubMed Web of Science ®Google Scholar
• Sanati H, Larsen R, Sheehan D, Ritchie J, Spelberg B, Ghannoum M. Penassay medium produces broad range of MICs of amphotericin B (Amph B) against clinical isolates of C. neoformans in a microdilution broth assay. 95th General Meeting of the American Society for Microbiology, Washington DC, 1995: abstr. n. F103.
   Google Scholar
• Colombo AL, Barchiesi F, McGough DA, Rinaldi MG. Comparison of E test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing. [Clin Microbiol 1995; 33: 535-540.
   Google Scholar
• Pfaller MA, Barry AL. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1994; 32: 1992-1996.
   PubMed Web of Science ®Google Scholar
• Tiballi RN, Fie X, Zarins LT, Revankar SG, Kauffman CA. Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol 1995; 33: 915-917.
   PubMed Web of Science ®Google Scholar
• Wanger A, Mills K, Rex JH. Comparison of E test and macrobroth dilution for antifungal susceptibility testing. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1994: N. D20.
   Google Scholar
• Ghannoum MA. Is antifungal susceptibility testing useful in guiding fluconazole therapy? Clin Infect Dis 1996; 22 (5): 161-165.
   Google Scholar
• Ghannoum MA, Rex J, Galgiani J. Susceptibility testing of fungi. Current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996; 34: 489-495.
   PubMed Web of Science ®Google Scholar
• Baily GG, Perry I'M, Denning DW, Mandai BK. Fluconazole resistant candidiasis in an FIIV cohort. AIDS 1994; 8: 787-792.
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 1995; 20: 634-640.
   PubMed Web of Science ®Google Scholar
• Bart-Delabesse E, Boiron P, Carlotti A, Dupont B. Candida albicans gentotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin Microbiol 1993;31:2933-2937.
   PubMed Web of Science ®Google Scholar
• Boken DJ, Swindells S, Rinaldi MG. Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018-1021.
   PubMed Web of Science ®Google Scholar
• DuPont B, Improvisi L, Eliaszewicz M, Pialoux G and the GEMO. Resistance of Candida albicans to fluconazole in AIDS patients. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy 1992: N. 1203.
   Google Scholar
• Heinic GS, Stevens DA, Greenspan D et al. Fluconazole-resistant Candida in AIDS patients. Report of two cases. Oral Surg Oral Med Oral Pathol 1993; 76: 711-715.
   PubMedGoogle Scholar
• Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. Clinically significant mucosal candidiasis resistant to fluconazole treatment in patiénts with AIDS. Clin Infect Dis 1994; 19: 684-686.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Rhine-Chalberg J, Redding SW et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. Clin Microbiol 1994; 32: 59-64.
   Google Scholar
• Redding S, Smith J, Farinacci G et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation of invitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18: 240-242.
   PubMed Web of Science ®Google Scholar
• Reynes J, Mallié M, André D, Janbon F, Bastide JM. Traitement et prophylaxie secondaire par fluconazole des candidoses oropharyngées des sujets VIH+. Analyse mycologique des échecs. Pathol Biol 1992; 40: 513-517.
   PubMedGoogle Scholar
• Sandven P, Bjorneklett A, Maeland A, and the Norwegian Yeast Study Group. Susceptibility testing of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrob Agents Chemother 1993; 37: 2443-2448.
   PubMed Web of Science ®Google Scholar
• Sangeorzan JA, Bradley SF, He X et al. Epidemiology of oral candidiasis in HIV infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97: 339-346.
   PubMed Web of Science ®Google Scholar
• Troillet N, Durussel C, Bille J, Glauser MP, Chave JP. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in FHV-infected patients. Eur J Clin Microbiol Infect Dis 1993; 12: 911-915.
   PubMed Web of Science ®Google Scholar
• Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD, and the NIAID Mycoses Study Group and the Candidemia Study Group. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole vs. amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrob Agents Chemother 1995; 39: 40-44.
   PubMed Web of Science ®Google Scholar
• Witt MD, Lewis RJ, Larsen RA et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 1996; 22: 322-328.
   PubMed Web of Science ®Google Scholar
• Larsen RA, Bozzette SA, Jones BE, Flaghighat D, Leal MA. Fluconazole combined with flucytosine for cryptococcal meningitis in persons with ATDS. Clin Infect Dis (in press) 1997.
   Google Scholar
• Milechike EN, Leal M, Flaubrich R, See R, Bozzette S, Larsen R. High dose fluconazole with and without flucytosine for AIDS associated cryptococcal meningitis. IX International Conference on AIDS/IV STD World Congress (Berlin). London: Wellcome Foundation. 1993, abstr.
   Google Scholar
• Rex JG, Pfaller M, Galgiani J et al. Development of interpretive breakpoints for susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 235-247.
   PubMed Web of Science ®Google Scholar
• Ganger G, Just-Nubling G, Eichel M, Hoika R, Stille W, Goethe J. Itraconazole solution in patients with nonresponse to fluconazole. IXth International Conference on AIDS, Berlin, 1993: abstr. P0-B09-1394.
   Google Scholar
• Ng T, Denning DW. Fluconazole resistance in Candida in patients with AIDS—a therapeutic approach. J Infect 1993; 26: 117-125.
   PubMed Web of Science ®Google Scholar